Evidence map›Paper›PMID 42909113›Full record

ReviewFrontiers in immunology2026

HIV-associated extranodal NK/T cell lymphoma, nasal type: a case report and literature review.

Junjie Wang, Lingyao Du, Tian Dong, Sha Zhao, Jie Ji, Hong Tang

Abstract readCase ReportsReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junjie WangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
Lingyao DuCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
Tian DongDepartment of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Sha ZhaoDepartment of Histology, West China Hospital of Sichuan University, Chengdu, China.
Jie JiDepartment of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Hong TangCenter of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extranodal NK/T-cell lymphoma (ENKTCL) is a rare aggressive lymphoma whose management is complicated by HIV-1 co-infection due to drug-drug interactions and overlapping toxicities, specifically the convergent hepatorenal and hematological toxicities resulting from the concurrent use of chemotherapeutic regimens and ART. We report a middle-aged HIV-1 positive man (CD4

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsHIV-1HIV InfectionsLymphoma, Extranodal NK-T-CellAsparaginaseDeoxycytidineDexamethasoneGemcitabineHumansMaleMiddle AgedTreatment OutcomeAsparaginaseDeoxycytidineDexamethasoneGemcitabineacquired immune deficiency syndromecase reportextranodal NK/T-cell lymphomaMDTtreatment

Identifiers

PMID42909113
PMCPMC13683803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.